{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:42:00Z","timestamp":1790451720462,"version":"4.1.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,23]],"date-time":"2016-04-23T00:00:00Z","timestamp":1461369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.reth.2016.04.001","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T09:00:21Z","timestamp":1464685221000},"page":"78-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Japan's challenges of translational regenerative medicine: Act on the safety of regenerative medicine"],"prefix":"10.1016","volume":"4","author":[{"given":"Morikuni","family":"Tobita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Konomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Torashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Taoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7979-7678","authenticated-orcid":false,"given":"Masahiro","family":"Kaminota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reth.2016.04.001_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nm0195-12","article-title":"Clinical trials in Japan","volume":"1","author":"Fukushima","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.reth.2016.04.001_bib2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.stem.2015.03.012","article-title":"New Japanese initiatives on stem cell therapies","volume":"16","author":"Konomi","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.reth.2016.04.001_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/2168479014526877","article-title":"New governmental regulatory system for stem cell-based therapies in Japan","volume":"48","author":"Hara","year":"2014","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.reth.2016.04.001_bib4","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nm0513-510","article-title":"Japan to offer fast-track approval path for stem cell therapies","volume":"19","author":"Cyranoski","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.reth.2016.04.001_bib5","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320416300098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320416300098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T10:59:53Z","timestamp":1536663593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320416300098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":5,"alternative-id":["S2352320416300098"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2016.04.001","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Japan's challenges of translational regenerative medicine: Act on the safety of regenerative medicine","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2016.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}